Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Rangel Rodrigues

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Expert Opinion on Therapeutic Patents|January 8, 2021
Inventive step assessment of top selling monoclonal antibodies in BrazilLouise Azulay Palavecino, Carlos Rangel Rodrigues, Murilo Lamim Bello, et al.
Toxicon : Official Journal of the International Society on Toxinology|October 19, 2006
Structure-function inferences based on molecular modeling, sequence-based methods and biological data analysis of snake venom lectinsPaula Alvarez Abreu, Magaly Girão Albuquerque, Carlos Rangel Rodrigues, et al.
Protein and Peptide Letters|August 20, 2009
Structural and pharmacological features of phospholipases A2 from snake venomsRafael Cisne de Paula, Helena Carla Castro, Carlos Rangel Rodrigues, et al.
Chemical Biology & Drug Design|January 25, 2012
Receptor-dependent 4D-QSAR analysis of peptidemimetic inhibitors of Trypanosoma cruzi trypanothione reductase with receptor-based alignmentSamuel Silva da Rocha Pita, Magaly Girão Albuquerque, Carlos Rangel Rodrigues, et al.
Molecular Pharmacology|February 2, 2023
Aryl Hydrocarbon Receptor as a Therapeutical Target of Environmentally Induced Skin ConditionsCaroline de Almeida Freitas Accioli, Michelle Sabrina da Silva, Bianca Aloise Maneira Corrêa Santos, et al.
ACS Omega|January 26, 2026
Machine Learning and Molecular Modeling for Drug Repurposing Targeting Potential PI3Kα Inhibitors in Post-CoViD-19 Pulmonary FibrosisCarine Ribeiro Dos Santos, Priscila Goes Camargo, Carlos Rangel Rodrigues, et al.
Scientific Reports|May 21, 2024
Py-CoMFA, docking, and molecular dynamics simulations of Leishmania (L.) amazonensis arginase inhibitorsPriscila Goes Camargo, Carine Ribeiro Dos Santos, Magaly Girão Albuquerque, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 7, 2013
Human thromboxane synthase: comparative modeling and docking evaluation with the competitive inhibitors Dazoxiben and OzagrelPlínio Cunha Sathler, Marcos Santana, André Luiz Lourenço, et al.
Journal of Molecular Modeling|November 28, 2019
Molecular modeling as a design tool for sunscreen candidates: a case study of bemotrizinolJoão Victor Teixeira Gomes, Anne Cherem Peixoto da Silva, Murilo Lamim Bello, et al.
Journal of Molecular Modeling|January 8, 2020
Correction to: Molecular modeling as a design tool for sunscreen candidates: a case study of bemotrizinolJoão Victor Teixeira Gomes, Anne Cherem Peixoto da Silva, Murilo Lamim Bello, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Expert Opinion on Therapeutic Patents|January 8, 2021
Inventive step assessment of top selling monoclonal antibodies in BrazilLouise Azulay Palavecino, Carlos Rangel Rodrigues, Murilo Lamim Bello, et al.
Toxicon : Official Journal of the International Society on Toxinology|October 19, 2006
Structure-function inferences based on molecular modeling, sequence-based methods and biological data analysis of snake venom lectinsPaula Alvarez Abreu, Magaly Girão Albuquerque, Carlos Rangel Rodrigues, et al.
Protein and Peptide Letters|August 20, 2009
Structural and pharmacological features of phospholipases A2 from snake venomsRafael Cisne de Paula, Helena Carla Castro, Carlos Rangel Rodrigues, et al.
Chemical Biology & Drug Design|January 25, 2012
Receptor-dependent 4D-QSAR analysis of peptidemimetic inhibitors of Trypanosoma cruzi trypanothione reductase with receptor-based alignmentSamuel Silva da Rocha Pita, Magaly Girão Albuquerque, Carlos Rangel Rodrigues, et al.
Molecular Pharmacology|February 2, 2023
Aryl Hydrocarbon Receptor as a Therapeutical Target of Environmentally Induced Skin ConditionsCaroline de Almeida Freitas Accioli, Michelle Sabrina da Silva, Bianca Aloise Maneira Corrêa Santos, et al.
ACS Omega|January 26, 2026
Machine Learning and Molecular Modeling for Drug Repurposing Targeting Potential PI3Kα Inhibitors in Post-CoViD-19 Pulmonary FibrosisCarine Ribeiro Dos Santos, Priscila Goes Camargo, Carlos Rangel Rodrigues, et al.
Scientific Reports|May 21, 2024
Py-CoMFA, docking, and molecular dynamics simulations of Leishmania (L.) amazonensis arginase inhibitorsPriscila Goes Camargo, Carine Ribeiro Dos Santos, Magaly Girão Albuquerque, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 7, 2013
Human thromboxane synthase: comparative modeling and docking evaluation with the competitive inhibitors Dazoxiben and OzagrelPlínio Cunha Sathler, Marcos Santana, André Luiz Lourenço, et al.
Journal of Molecular Modeling|November 28, 2019
Molecular modeling as a design tool for sunscreen candidates: a case study of bemotrizinolJoão Victor Teixeira Gomes, Anne Cherem Peixoto da Silva, Murilo Lamim Bello, et al.
Journal of Molecular Modeling|January 8, 2020
Correction to: Molecular modeling as a design tool for sunscreen candidates: a case study of bemotrizinolJoão Victor Teixeira Gomes, Anne Cherem Peixoto da Silva, Murilo Lamim Bello, et al.
Pageof 10